SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000929638-24-003216
Filing Date
2024-09-24
Accepted
2024-09-24 16:03:22
Documents
2

Document Format Files

Seq Description Document Type Size
1 sc13ga.htm SC 13G/A 63579
2 image0.jpg GRAPHIC 52360
  Complete submission text file 0000929638-24-003216.txt   137532
Mailing Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211
Business Address 8840 WILSHIRE BLVD 2ND FLOOR BEVERLY HILLS CA 90211 (310) 358-3200
CAPRICOR THERAPEUTICS, INC. (Subject) CIK: 0001133869 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-81959 | Film No.: 241320201
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 14 NISHINOSHO MONGUCHI CHO KISSHOIN MINAMIKU KYOTO M0 00000
Business Address 14 NISHINOSHO MONGUCHI CHO KISSHOIN MINAMIKU KYOTO M0 00000 81 75 321 9104
Nippon Shinyaku Co Ltd (Filed by) CIK: 0001361865 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13G/A